This is a $398,972 Project Grant awarded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) federal grant program. The grant is focused on studying hospital care practices and outcomes for newborns with prenatal substance exposure, with the goal of identifying high-quality and equitable care approaches that can be implemented across U.S. birth hospitals. The project will be conducted in partnership with the Better...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $900,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Arizona Health Care Cost Containment System (AHCCCS), Arizona's state Medicaid agency. The grant, titled "STATE PILOT PROGRAM FOR TREATMENT FOR PREGNANT AND POSTPARTUM WOMEN (PPW-PLT) - THE OVERARCHING GOAL OF THE NARWHAL (NORTHERN ARIZONA RURAL WELLNESS &...
The federal Project Grant award of $399,111.00 from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program aims to increase postpartum primary care engagement, quality, and experience by strengthening obstetric-to-primary care coordination. The primary intervention includes default PCP visit scheduling, tailored patient nudge messages, ongoing care recommendations sent to the PCP, and a summary of recommendations...
The Department of Health and Human Services, Health Resources and Services Administration (HRSA) awarded a $400,000 Project Grant under the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110) to the Delaware Division of Public Health. The grant will fund the implementation of the Postpartum Discharge Transition (PPDT) Patient Safety Module of the Alliance for Innovation on Maternal Health (AIM) across 6 birthing hospitals in Delaware. The key goals are to: Increase postpartum...
This $1,873,868 Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA 93.279 - Drug Use and Addiction Research Programs, aims to develop and evaluate an intervention to improve retention in substance use disorder (SUD) treatment for pregnant patients. The key products and services to be delivered include: Developing and piloting a standardized approach to identify and address social determinants of health (SDOH) that impact SUD treatment retention for pregnant...
This $945,397 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and evaluate a Collaborative Care Model (CCM) for treating pregnant and postpartum persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt an existing CCM for rural and low-resource obstetric sites; 2) create a common data model to harmonize data across study sites; 3)...
The federal Project Grant award of $1,899,958, funded by the Health Resources and Services Administration (HRSA) under the Maternal and Child Health Federal Consolidated Programs (CFDA 93.110), supports the SAFEST (SBIRT and FASD Education, Support and Technical Assistance) CHOICE National Learning Collaborative. This program, a partnership between Boston Medical Center Corporation and Proof Alliance, aims to improve the ability of primary care providers and their teams to screen for alcohol use...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $900,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS). The grant aims to establish the PPW HEALING, OVERCOME, PERSEVERE, AND EMPOWER (HOPE) INITIATIVE, a collaborative effort between ODMHSAS, Southern Oklahoma Treatment Services (SOTS), and...
This $750,000 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program will enable Marshfield Clinic, Inc., a non-profit healthcare organization, to partner with community coalitions in five rural Wisconsin counties to address underage drinking and promote mental health among priority populations including rural, tribal, and LGBTQ youth....
The Sauk County Navigating Recovery Project is a $1,000,000 federal grant award made by the Bureau of Justice Assistance (BJA) under the Comprehensive Opioid, Stimulant, and Other Substance Use Program (CFDA 16.838). This 3-year project aims to sustainably reduce the impact of substance use disorders on Sauk County, Wisconsin, particularly for those experiencing health disparities. The key components of the project include: 1) Deploying response teams of EMS professionals and peer recovery...